Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON28674Active, not recruiting
Open-label, single-arm trial of tobramycin and colistin in cystic fibrosis (CF), sponsored by HagaZiekenhuis. Primary endpoints: Area under the concentration-time curve, Time to maximum concentration and 3 more. Started Jun 2013; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON28674.